Acorda Therapeutics reported $187.69M in Debt for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Acorda Therapeutics ACOR:US USD 187.69M 2.71M
Agios Pharmaceuticals AGIO:US USD 1.14M 84K
Amgen AMGN:US USD 38.7B 2.18B
Aptinyx Inc APTX:US USD 24.71M 211K
Biogen BIIB:US USD 6.28B 998M
Biomarin Pharmaceutical BMRN:US USD 1.08B 986K
Clovis Oncology CLVS:US USD 660.38M 13.49M
Cytokinetics CYTK:US USD 610.73M 411.31M
Enanta Pharmaceuticals ENTA:US USD 1.42M 83K
GlaxoSmithKline GSK:LN GBP 22.12B 4M
Halozyme Therapeutics HALO:US USD 1.5B 258.29M
Heron Therapeutics HRTX:US USD 149.23M 52K
Insmed INSM:US USD 807.82M 491K
Ligand Pharmaceuticals LGND:US USD 76.65M 38.38M
Mannkind MNKD:US USD 377.03M 564K
Merck MRK:GR EUR 11.05B 753M
Moderna Inc MRNA:US USD 1.15B 384M
Neurocrine Biosciences NBIX:US USD 169.2M 200K
Novartis NOVN:VX USD 28.44B 2.59B
Teva Pharmaceutical TEVA:IT USD 21.27B 816M
Vertex Pharmaceuticals VRTX:US USD 442.3M 40M